UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Update on Pan-Deacetylase Inhibitors in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e8-e9

Cavenagh, J.D

2015

Volltextzugriff (PDF)

Durable Remissions of Myelodysplastic Syndrome and Acute Myeloid Leukemia After Reduced-Intensity Allografting

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3060-3065

2003

Volltextzugriff (PDF)

124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY

Leukemia research, 2015-04, Vol.39, p.S63-S64

2015

Volltextzugriff (PDF)

96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY

Leukemia research, 2015-04, Vol.39, p.S48-S49

2015

Volltextzugriff (PDF)

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

Leukemia, 2008-04, Vol.22 (4), p.842-849

2008

Volltextzugriff (PDF)

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Volltextzugriff (PDF)

Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra

QJM : An International Journal of Medicine, 2015-06, Vol.108 (6), p.497-501

2015

Volltextzugriff (PDF)

The Utility Of Minimal Residual Disease (MRD) Assessment At First Relapse: Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial

Blood, 2013-11, Vol.122 (21), p.3378-3378

2013

Volltextzugriff (PDF)

A Second Autologous Stem Cell Transplant (ASCT2) Induces Superior Durability Of Response (DuR) Following Bortezomib-Containing Re-Induction Therapy For Relapsed Multiple Myeloma (MM): Final Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial

Blood, 2013-11, Vol.122 (21), p.765-765

2013

Volltextzugriff (PDF)

The Safety, Pharmacokinetics and Pharmacodynamics of KW-2478, a Novel Hsp90 Antagonist, in Patients with B-Cell Malignancies: A First-in-Man, Phase I, Multicentre, Open-Label, Dose Escalation Study

Blood, 2008-11, Vol.112 (11), p.2777-2777

2008

Volltextzugriff (PDF)

Low dose antithymocyte globulin for the treatment of older patients with aplastic anaemia

Leukemia research, 2006-12, Vol.30 (12), p.1517-1520

2006

Volltextzugriff (PDF)

Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry

Cytometry (New York, N.Y.), 1999-08, Vol.38 (4), p.153-160

1999

Volltextzugriff (PDF)

Treatment of acute myeloid leukaemia in pregnancy

The Lancet (British edition), 1995-08, Vol.346 (8972), p.441-442

1995

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(4)
Leukemia Research
(3)
Bone Marrow Transplantation
(1)
Clinical Lymphoma, Myeloma And Leukemia
(1)
Cytometry
(1)
Journal Of Clinical Oncology
(1)
Lancet
(1)
Leukemia
(1)
Qjm
(1)
Qjm : An International Journal Of Medicine
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Update on Pan-Deacetylase Inhibitors in Multiple Myeloma

Durable Remissions of Myelodysplastic Syndrome and Acute Myeloid Leukemia After Reduced-Intensity Allografting

124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY

96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra

The Utility Of Minimal Residual Disease (MRD) Assessment At First Relapse: Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial

A Second Autologous Stem Cell Transplant (ASCT2) Induces Superior Durability Of Response (DuR) Following Bortezomib-Containing Re-Induction Therapy For Relapsed Multiple Myeloma (MM): Final Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial

The Safety, Pharmacokinetics and Pharmacodynamics of KW-2478, a Novel Hsp90 Antagonist, in Patients with B-Cell Malignancies: A First-in-Man, Phase I, Multicentre, Open-Label, Dose Escalation Study

Low dose antithymocyte globulin for the treatment of older patients with aplastic anaemia

Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry

Treatment of acute myeloid leukaemia in pregnancy

Suchergebnisse filtern